{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:05:53Z","timestamp":1761541553631,"version":"3.37.3"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007176","name":"Scuola Superiore Sant'Anna","doi-asserted-by":"publisher","award":["Internal funds"],"award-info":[{"award-number":["Internal funds"]}],"id":[{"id":"10.13039\/501100007176","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s10741-020-10016-2","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T19:03:56Z","timestamp":1598382236000},"page":"371-380","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure"],"prefix":"10.1007","volume":"26","author":[{"given":"Iman","family":"Razeghian-Jahromi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Javad","family":"Zibaeenezhad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhibing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elyaspour","family":"Zahra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razmkhah","family":"Mahboobeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicenzo","family":"Lionetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"key":"10016_CR1","doi-asserted-by":"crossref","unstructured":"Moccia F, Gerbino A, Lionetti V, Miragoli M, Munaron L, Pagliaro P et al (2020) COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches. GeroScience.:1\u201329","DOI":"10.1007\/s11357-020-00198-w"},{"key":"10016_CR2","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1016\/j.jacc.2020.04.028","volume":"75","author":"A Brojakowska","year":"2020","unstructured":"Brojakowska A, Narula J, Shimony R, Bander J (2020) Clinical implications of SARS-Cov2 interaction with renin angiotensin system. J Am Coll Cardiol 75:3085\u20133095","journal-title":"J Am Coll Cardiol"},{"key":"10016_CR3","doi-asserted-by":"publisher","unstructured":"Rahimi F, Abadi ATB (2020) Challenges of managing the asymptomatic carriers of SARS-CoV-2. Travel Med Infect Dis 101677. https:\/\/doi.org\/10.1016\/j.tmaid.2020.101677","DOI":"10.1016\/j.tmaid.2020.101677"},{"issue":"6483","key":"10016_CR4","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, Graham BS, McLellan JS (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 367(6483):1260\u20131263","journal-title":"Science."},{"key":"10016_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.abc1669","volume":"369","author":"MM Lamers","year":"2020","unstructured":"Lamers MM, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem TI, Ravelli RBG, Paul van Schayck J, Mykytyn AZ, Duimel HQ, van Donselaar E, Riesebosch S, Kuijpers HJH, Schipper D, van de Wetering WJ, de Graaf M, Koopmans M, Cuppen E, Peters PJ, Haagmans BL, Clevers H (2020) SARS-CoV-2 productively infects human gut enterocytes. Science. 369:50\u201354","journal-title":"Science."},{"issue":"5","key":"10016_CR6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","volume":"26","author":"W Sungnak","year":"2020","unstructured":"Sungnak W, Huang N, B\u00e9cavin C, Berg M, Queen R, Litvinukova M et al (2020) SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med 26(5):681\u2013687","journal-title":"Nat Med"},{"key":"10016_CR7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jtos.2020.06.007","volume":"18","author":"L Zhou","year":"2020","unstructured":"Zhou L, Xu Z, Castiglione GM, Soiberman US, Eberhart CG, Duh EJ (2020) ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection. Ocular Surf 18:537\u2013544","journal-title":"Ocular Surf"},{"key":"10016_CR8","doi-asserted-by":"publisher","unstructured":"Guo J, Wei X, Li Q, Li L, Yang Z, Shi Y, Qin Y, Zhang X, Wang X, Zhi X, Meng D (2020) Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury. J Cell Physiol. https:\/\/doi.org\/10.1002\/jcp.29802","DOI":"10.1002\/jcp.29802"},{"issue":"6","key":"10016_CR9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/jmv.25728","volume":"92","author":"YC Li","year":"2020","unstructured":"Li YC, Bai WZ, Hashikawa T (2020) The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 92(6):552\u2013555","journal-title":"J Med Virol"},{"key":"10016_CR10","doi-asserted-by":"publisher","unstructured":"Gattinoni L, Chiumello D, Rossi S (2020) COVID-19 pneumonia: ARDS or not? Crit Care 24:154. https:\/\/doi.org\/10.1186\/s13054-020-02880-z","DOI":"10.1186\/s13054-020-02880-z"},{"issue":"10223","key":"10016_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J\u2019, Yu T, Zhang X, Zhang L (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507\u2013513","journal-title":"Lancet"},{"issue":"10223","key":"10016_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497\u2013506","journal-title":"Lancet"},{"key":"10016_CR13","doi-asserted-by":"publisher","unstructured":"Russo V, Rago A, Carbone A, Bottino R, Ammendola E, Della Cioppa N, Galante D, Golino P, Nigro G (2020) Atrial fibrillation in COVID-19: from epidemiological association to pharmacological implications. J Cardiovasc Pharmacol 76:138\u2013145. https:\/\/doi.org\/10.1097\/FJC.0000000000000854","DOI":"10.1097\/FJC.0000000000000854"},{"key":"10016_CR14","doi-asserted-by":"crossref","unstructured":"Iba T, Levy JH, Levi M, Connors JM, Thachil J Coagulopathy of coronavirus disease 2019. Crit Care Med:2020","DOI":"10.1097\/CCM.0000000000004458"},{"key":"10016_CR15","doi-asserted-by":"publisher","unstructured":"Yang C, Jin Z (2020) An acute respiratory infection runs into the most common noncommunicable epidemic\u2014COVID-19 and cardiovascular diseases. JAMA Cardiol 5:743. https:\/\/doi.org\/10.1001\/jamacardio.2020.0934","DOI":"10.1001\/jamacardio.2020.0934"},{"issue":"7","key":"10016_CR16","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.hrthm.2011.02.016","volume":"8","author":"M Alasady","year":"2011","unstructured":"Alasady M, Abhayaratna WP, Leong DP, Lim HS, Abed HS, Brooks AG, Mattchoss S, Roberts-Thomson KC, Worthley MI, Chew DP, Sanders P (2011) Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction. Heart Rhythm 8(7):955\u2013960","journal-title":"Heart Rhythm"},{"issue":"5","key":"10016_CR17","doi-asserted-by":"publisher","first-page":"e005868","DOI":"10.1161\/JAHA.117.005868","volume":"6","author":"S Chandran","year":"2017","unstructured":"Chandran S, Watkins J, Abdul-Aziz A, Shafat M, Calvert PA, Bowles KM et al (2017) Inflammatory differences in plaque erosion and rupture in patients with ST-segment elevation myocardial infarction. J Am Heart Assoc 6(5):e005868","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10016_CR18","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/ejhf.1482","volume":"21","author":"G Markousis-Mavrogenis","year":"2019","unstructured":"Markousis-Mavrogenis G, Tromp J, Ouwerkerk W, Devalaraja M, Anker SD, Cleland JG, Dickstein K, Filippatos GS, Harst P, Lang CC, Metra M, Ng LL, Ponikowski P, Samani NJ, Zannad F, Zwinderman AH, Hillege HL, Veldhuisen DJ, Kakkar R, Voors AA, Meer P (2019) The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study. Eur J Heart Fail 21(8):965\u2013973","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10016_CR19","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China. Jama 323(11):1061\u20131069","journal-title":"Jama"},{"issue":"7798","key":"10016_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270\u2013273","journal-title":"Nature"},{"key":"10016_CR21","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1136\/heartjnl-2020-317062","volume":"106","author":"X Li","year":"2020","unstructured":"Li X, Guan B, Su T, Liu W, Chen M, Waleed KB et al (2020) Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis. Heart. 106:1142\u20131147","journal-title":"Heart."},{"issue":"19","key":"10016_CR22","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/eurheartj\/ehaa388","volume":"41","author":"RM Inciardi","year":"2020","unstructured":"Inciardi RM, Adamo M, Lupi L, Cani DS, Di Pasquale M, Tomasoni D et al (2020) Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J 41(19):1821\u20131829","journal-title":"Eur Heart J"},{"key":"10016_CR23","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","volume":"5","author":"S Shi","year":"2020","unstructured":"Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C (2020) Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 5:802","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10016_CR24","first-page":"H1426","volume":"316","author":"N Escobales","year":"2019","unstructured":"Escobales N, Nu\u00f1ez RE, Javadov S (2019) Mitochondrial angiotensin receptors and cardioprotective pathways. Am J Phys Heart Circ Phys 316(6):H1426\u2013H1H38","journal-title":"Am J Phys Heart Circ Phys"},{"issue":"4","key":"10016_CR25","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1172\/JCI23378","volume":"115","author":"SD Crowley","year":"2005","unstructured":"Crowley SD, Gurley SB, Oliverio MI, Pazmino AK, Griffiths R, Flannery PJ, Spurney RF, Kim HS, Smithies O, le TH, Coffman TM (2005) Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 115(4):1092\u20131099","journal-title":"J Clin Invest"},{"issue":"1","key":"10016_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10557-005-6900-8","volume":"19","author":"P Pagliaro","year":"2005","unstructured":"Pagliaro P, Penna C (2005) Rethinking the renin-angiotensin system and its role in cardiovascular regulation. Cardiovasc Drugs Ther 19(1):77\u201387","journal-title":"Cardiovasc Drugs Ther"},{"issue":"8","key":"10016_CR27","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.cardfail.2010.06.054","volume":"16","author":"GY Oudit","year":"2010","unstructured":"Oudit GY, Zhong J, Basu R, Guo D, Penninger JM, Kassiri Z (2010) Angiotensin converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis and diastolic dysfunction. J Card Fail 16(8):S16","journal-title":"J Card Fail"},{"key":"10016_CR28","volume-title":"Simultaneous exposure to nitric oxide inhibition and angiotensin II overload: is it a murine model of mitochondrial dysfunction in nonischemic heart failure?","author":"V Lionetti","year":"2016","unstructured":"Lionetti V (2016) Simultaneous exposure to nitric oxide inhibition and angiotensin II overload: is it a murine model of mitochondrial dysfunction in nonischemic heart failure? American Physiological Society Bethesda, MD"},{"issue":"1","key":"10016_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10741-019-09855-5","volume":"25","author":"NR Pugliese","year":"2020","unstructured":"Pugliese NR, Masi S, Taddei S (2020) The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure. Heart Fail Rev 25(1):31\u201342","journal-title":"Heart Fail Rev"},{"issue":"4","key":"10016_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1023\/A:1020714518246","volume":"7","author":"M de Gasparo","year":"2002","unstructured":"de Gasparo M (2002) Angiotensin II and nitric oxide interaction. Heart Fail Rev 7(4):347\u2013358","journal-title":"Heart Fail Rev"},{"issue":"4","key":"10016_CR31","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1161\/01.ATV.0000258415.32883.bf","volume":"27","author":"U Landmesser","year":"2007","unstructured":"Landmesser U, Spiekermann S, Preuss C, Sorrentino S, Fischer D, Manes C, Mueller M, Drexler H (2007) Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease. Arterioscler Thromb Vasc Biol 27(4):943\u2013948","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10016_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.atherosclerosis.2014.06.011","volume":"236","author":"P Clancy","year":"2014","unstructured":"Clancy P, Koblar SA, Golledge J (2014) Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation. Atherosclerosis. 236(1):108\u2013115","journal-title":"Atherosclerosis."},{"key":"10016_CR33","doi-asserted-by":"publisher","first-page":"30048","DOI":"10.1038\/srep30048","volume":"6","author":"A Dushpanova","year":"2016","unstructured":"Dushpanova A, Agostini S, Ciofini E, Cabiati M, Casieri V, Matteucci M, del Ry S, Clerico A, Berti S, Lionetti V (2016) Gene silencing of endothelial von Willebrand factor attenuates angiotensin II-induced endothelin-1 expression in porcine aortic endothelial cells. Sci Rep 6:30048","journal-title":"Sci Rep"},{"issue":"6832","key":"10016_CR34","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1136\/bmj.304.6832.941","volume":"304","author":"T Hedner","year":"1992","unstructured":"Hedner T, Samuelsson O, Lunde H, Lindholm L, Andren L, Wiholm B-E (1992) Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors. Br Med J 304(6832):941\u2013946","journal-title":"Br Med J"},{"issue":"8","key":"10016_CR35","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJM200208223470820","volume":"347","author":"J Nussberger","year":"2002","unstructured":"Nussberger J, Cugno M, Cicardi M (2002) Bradykinin-mediated angioedema. N Engl J Med 347(8):621\u2013622","journal-title":"N Engl J Med"},{"issue":"2","key":"10016_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1081-1206(10)61206-9","volume":"95","author":"RY Lin","year":"2005","unstructured":"Lin RY, Cannon AG, Teitel AD (2005) Pattern of hospitalizations for angioedema in New York between 1990 and 2003. Ann Allergy Asthma Immunol 95(2):159\u2013166","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10016_CR37","doi-asserted-by":"crossref","unstructured":"Fukuta H, Goto T, Wakami K, Kamiya T, Ohte N (2020) Effect of renin-angiotensin system inhibition on cardiac structure and function and exercise capacity in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials. Heart Fail Rev:1\u20138","DOI":"10.1007\/s10741-020-10013-5"},{"issue":"24","key":"10016_CR38","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1016\/j.jacc.2016.09.946","volume":"68","author":"C Fattah","year":"2016","unstructured":"Fattah C, Nather K, McCarroll CS, Hortigon-Vinagre MP, Zamora V, Flores-Munoz M et al (2016) Gene therapy with angiotensin-(1-9) preserves left ventricular systolic function after myocardial infarction. J Am Coll Cardiol 68(24):2652\u20132666","journal-title":"J Am Coll Cardiol"},{"issue":"4\u20135","key":"10016_CR39","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10741-011-9259-x","volume":"17","author":"W Wang","year":"2012","unstructured":"Wang W, Bodiga S, Das SK, Lo J, Patel V, Oudit GY (2012) Role of ACE2 in diastolic and systolic heart failure. Heart Fail Rev 17(4\u20135):683\u2013691","journal-title":"Heart Fail Rev"},{"key":"10016_CR40","doi-asserted-by":"publisher","unstructured":"Ferrario CM, Trask AJ, Jessup JA (2005) Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1\u20137) in regulation of cardiovascular function. Am J Phys Heart Circ Phys 289(6):H2281\u2013H2H90. https:\/\/doi.org\/10.1152\/ajpheart.00618.2005","DOI":"10.1152\/ajpheart.00618.2005"},{"issue":"3","key":"10016_CR41","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/bph.12159","volume":"169","author":"A Simoes e Silva","year":"2013","unstructured":"Simoes e Silva A, Silveira K, Ferreira A, Teixeira M (2013) ACE2, angiotensin-(1-7) and M as receptor axis in inflammation and fibrosis. Br J Pharmacol 169(3):477\u2013492","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10016_CR42","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","volume":"21","author":"A Khan","year":"2017","unstructured":"Khan A, Benthin C, Zeno B, Albertson TE, Boyd J, Christie JD, Hall R, Poirier G, Ronco JJ, Tidswell M, Hardes K, Powley WM, Wright TJ, Siederer SK, Fairman DA, Lipson DA, Bayliffe AI, Lazaar AL (2017) A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Crit Care 21(1):234","journal-title":"Crit Care"},{"issue":"5","key":"10016_CR43","doi-asserted-by":"publisher","first-page":"5988","DOI":"10.1002\/jcp.27147","volume":"234","author":"XF Pang","year":"2019","unstructured":"Pang XF, Liu RM, Xia YF (2019) Effects of inhibitors of the renin-angiotensin system on reducing blood pressure and expression of inflammatory factors in CHD patients: a network meta-analysis. J Cell Physiol 234(5):5988\u20135997","journal-title":"J Cell Physiol"},{"issue":"9117","key":"10016_CR44","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","volume":"351","author":"J Nussberger","year":"1998","unstructured":"Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A (1998) Plasma bradykinin in angio-oedema. Lancet 351(9117):1693\u20131697","journal-title":"Lancet"},{"issue":"1","key":"10016_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1161\/HYPERTENSIONAHA.107.096552","volume":"51","author":"JB Byrd","year":"2008","unstructured":"Byrd JB, Touzin K, Sile S, Gainer JV, Yu C, Nadeau J, Adam A, Brown NJ (2008) Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor\u2013associated angioedema. Hypertension. 51(1):141\u2013147","journal-title":"Hypertension."},{"issue":"5","key":"10016_CR46","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s40256-016-0173-4","volume":"16","author":"S Taddei","year":"2016","unstructured":"Taddei S, Bortolotto L (2016) Unraveling the pivotal role of bradykinin in ACE inhibitor activity. Am J Cardiovasc Drugs 16(5):309\u2013321","journal-title":"Am J Cardiovasc Drugs"},{"issue":"1\u20133","key":"10016_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2007.07.061","volume":"577","author":"C Ceconi","year":"2007","unstructured":"Ceconi C, Francolini G, Olivares A, Comini L, Bachetti T, Ferrari R (2007) Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE. Eur J Pharmacol 577(1\u20133):1\u20136","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10016_CR48","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2165\/00003495-200262020-00003","volume":"62","author":"S Taddei","year":"2002","unstructured":"Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A (2002) Effects of antihypertensive drugs on endothelial dysfunction. Drugs. 62(2):265\u2013284","journal-title":"Drugs."},{"issue":"9","key":"10016_CR49","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1161\/01.CIR.101.9.948","volume":"101","author":"JA Suwaidi","year":"2000","unstructured":"Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A (2000) Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 101(9):948\u2013954","journal-title":"Circulation."},{"issue":"16","key":"10016_CR50","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1161\/01.CIR.101.16.1899","volume":"101","author":"V Sch\u00e4chinger","year":"2000","unstructured":"Sch\u00e4chinger V, Britten MB, Zeiher AM (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 101(16):1899\u20131906","journal-title":"Circulation."},{"issue":"1","key":"10016_CR51","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1161\/01.HYP.29.1.488","volume":"29","author":"D-z Wang","year":"1997","unstructured":"Wang D-z, Chao L, Chao J (1997) Hypotension in transgenic mice overexpressing human bradykinin B2 receptor. Hypertension. 29(1):488\u2013493","journal-title":"Hypertension."},{"issue":"11","key":"10016_CR52","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1291\/hypres.29.865","volume":"29","author":"J Agata","year":"2006","unstructured":"Agata J, Ura N, Yoshida H, Shinshi Y, Sasaki H, Hyakkoku M et al (2006) Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme. Hypertens Res 29(11):865\u2013874","journal-title":"Hypertens Res"},{"issue":"3","key":"10016_CR53","first-page":"H1013","volume":"289","author":"M Igase","year":"2005","unstructured":"Igase M, Strawn WB, Gallagher PE, Geary RL, Ferrario CM (2005) Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1\u20137) expression in the aorta of spontaneously hypertensive rats. Am J Phys Heart Circ Phys 289(3):H1013\u2013H10H9","journal-title":"Am J Phys Heart Circ Phys"},{"issue":"2","key":"10016_CR54","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/10641960903254430","volume":"32","author":"Y Kiya","year":"2010","unstructured":"Kiya Y, Miura S-I, Fujino M, Imaizumi S, Karnik SS, Saku K (2010) Clinical and pharmacotherapeutic relevance of the double-chain domain of the angiotensin II type 1 receptor blocker olmesartan. Clin Exp Hypertens 32(2):129\u2013136","journal-title":"Clin Exp Hypertens"},{"issue":"7","key":"10016_CR55","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11906-018-0859-x","volume":"20","author":"WJ Kostis","year":"2018","unstructured":"Kostis WJ, Shetty M, Chowdhury YS, Kostis JB (2018) ACE inhibitor-induced angioedema: a review. Curr Hypertens Rep 20(7):55","journal-title":"Curr Hypertens Rep"},{"issue":"9","key":"10016_CR56","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/01.RES.0000187500.24964.7A","volume":"97","author":"S Keidar","year":"2005","unstructured":"Keidar S, Gamliel-Lazarovich A, Kaplan M, Pavlotzky E, Hamoud S, Hayek T, Karry R, Abassi Z (2005) Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients. Circ Res 97(9):946\u2013953","journal-title":"Circ Res"},{"key":"10016_CR57","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1093\/eurheartj\/ehaa373","volume":"41","author":"IE Sama","year":"2020","unstructured":"Sama IE, Ravera A, Santema BT, van Goor H, ter Maaten JM, Cleland JG et al (2020) Circulating plasma concentrations of ACE2 in men and women with heart failure and effects of renin-angiotensin-aldosterone-inhibitors. Eur Heart J 41:1810\u20131817","journal-title":"Eur Heart J"},{"issue":"2","key":"10016_CR58","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.3892\/mmr.2017.6848","volume":"16","author":"J Wang","year":"2017","unstructured":"Wang J, He W, Guo L, Zhang Y, Li H, Han S, Shen D (2017) The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction. Mol Med Rep 16(2):1973\u20131981","journal-title":"Mol Med Rep"},{"issue":"2","key":"10016_CR59","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1161\/01.HYP.31.2.699","volume":"31","author":"SN Iyer","year":"1998","unstructured":"Iyer SN, Chappell MC, Averill DB, Diz DI, Ferrario CM (1998) Vasodepressor actions of angiotensin-(1\u20137) unmasked during combined treatment with lisinopril and losartan. Hypertension. 31(2):699\u2013705","journal-title":"Hypertension."},{"issue":"6","key":"10016_CR60","first-page":"H2373","volume":"295","author":"PE Gallagher","year":"2008","unstructured":"Gallagher PE, Ferrario CM, Tallant EA (2008) Regulation of ACE2 in cardiac myocytes and fibroblasts. Am J Phys Heart Circ Phys 295(6):H2373\u2013H23H9","journal-title":"Am J Phys Heart Circ Phys"},{"issue":"8","key":"10016_CR61","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L, Zhang B, Liu G, Wang Z, Chappell M, Liu Y, Zheng D, Leibbrandt A, Wada T, Slutsky AS, Liu D, Qin C, Jiang C, Penninger JM (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury. Nat Med 11(8):875\u2013879","journal-title":"Nat Med"},{"key":"10016_CR62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","volume":"76","author":"P Verdecchia","year":"2020","unstructured":"Verdecchia P, Cavallini C, Spanevello A, Angeli F (2020) The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med 76:14\u201320","journal-title":"Eur J Intern Med"},{"key":"10016_CR63","doi-asserted-by":"publisher","first-page":"104350","DOI":"10.1016\/j.yexmp.2019.104350","volume":"113","author":"R Ye","year":"2020","unstructured":"Ye R, Liu Z (2020) ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway. Exp Mol Pathol 113:104350","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"10016_CR64","doi-asserted-by":"publisher","first-page":"R24","DOI":"10.1186\/cc8887","volume":"14","author":"KC Doerschug","year":"2010","unstructured":"Doerschug KC, Delsing AS, Schmidt GA, Ashare A (2010) Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis. Crit Care 14(1):R24","journal-title":"Crit Care"},{"issue":"3","key":"10016_CR65","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s001340051152","volume":"26","author":"M Wenz","year":"2000","unstructured":"Wenz M, Hoffmann B, Bohlender J, Kaczmarczyk G (2000) Angiotensin II formation and endothelin clearance in ARDS patients in supine and prone positions. Intensive Care Med 26(3):292\u2013298","journal-title":"Intensive Care Med"},{"key":"10016_CR66","doi-asserted-by":"crossref","unstructured":"Hemnes AR, Rathinasabapathy A, Austin EA, Brittain EL, Carrier EJ, Chen X et al (2018) A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension. Eur Respir J 51(6)","DOI":"10.1183\/13993003.02638-2017"},{"issue":"2","key":"10016_CR67","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","volume":"13","author":"L Fagerberg","year":"2014","unstructured":"Fagerberg L, Hallstr\u00f6m BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S, Danielsson A, Edlund K, Asplund A, Sj\u00f6stedt E, Lundberg E, Szigyarto CAK, Skogs M, Takanen JO, Berling H, Tegel H, Mulder J, Nilsson P, Schwenk JM, Lindskog C, Danielsson F, Mardinoglu A, Sivertsson \u00c5, von Feilitzen K, Forsberg M, Zwahlen M, Olsson IM, Navani S, Huss M, Nielsen J, Ponten F, Uhl\u00e9n M (2014) Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics 13(2):397\u2013406","journal-title":"Mol Cell Proteomics"},{"key":"10016_CR68","doi-asserted-by":"crossref","unstructured":"Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ (2000) A human homolog of angiotensin-converting enzyme cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275(43):33238\u201333243","DOI":"10.1074\/jbc.M002615200"},{"key":"10016_CR69","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M\u00fcller MA, Drosten C, P\u00f6hlmann S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 181:271\u2013280.e8","journal-title":"Cell."},{"issue":"29","key":"10016_CR70","doi-asserted-by":"publisher","first-page":"7118","DOI":"10.1021\/bi00243a012","volume":"30","author":"MR Ehlers","year":"1991","unstructured":"Ehlers MR, Riordan JF (1991) Angiotensin-converting enzyme: zinc-and inhibitor-binding stoichiometries of the somatic and testis isozymes. Biochemistry. 30(29):7118\u20137126","journal-title":"Biochemistry."},{"issue":"24","key":"10016_CR71","doi-asserted-by":"publisher","first-page":"9386","DOI":"10.1073\/pnas.85.24.9386","volume":"85","author":"F Soubrier","year":"1988","unstructured":"Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, Corvol P (1988) Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci 85(24):9386\u20139390","journal-title":"Proc Natl Acad Sci"},{"issue":"6891","key":"10016_CR72","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nature00786","volume":"417","author":"MA Crackower","year":"2002","unstructured":"Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira-dos-Santos AJ, da Costa J, Zhang L, Pei Y, Scholey J, Ferrario CM, Manoukian AS, Chappell MC, Backx PH, Yagil Y, Penninger JM (2002) Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 417(6891):822\u2013828","journal-title":"Nature."},{"issue":"6","key":"10016_CR73","first-page":"H2356","volume":"289","author":"M Iwata","year":"2005","unstructured":"Iwata M, Cowling RT, Gurantz D, Moore C, Zhang S, Yuan JX-J, Greenberg BH (2005) Angiotensin-(1\u20137) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects. Am J Phys Heart Circ Phys 289(6):H2356\u2013H2H63","journal-title":"Am J Phys Heart Circ Phys"},{"issue":"22","key":"10016_CR74","doi-asserted-by":"publisher","first-page":"7809","DOI":"10.1073\/pnas.0711241105","volume":"105","author":"S Haga","year":"2008","unstructured":"Haga S, Yamamoto N, Nakai-Murakami C, Osawa Y, Tokunaga K, Sata T, Yamamoto N, Sasazuki T, Ishizaka Y (2008) Modulation of TNF-\u03b1-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-\u03b1 production and facilitates viral entry. Proc Natl Acad Sci 105(22):7809\u20137814","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"10016_CR75","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nrmicro2147","volume":"7","author":"S Perlman","year":"2009","unstructured":"Perlman S, Netland J (2009) Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol 7(6):439\u2013450","journal-title":"Nat Rev Microbiol"},{"key":"10016_CR76","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","volume":"3","author":"F Li","year":"2016","unstructured":"Li F (2016) Structure, function, and evolution of coronavirus spike proteins. Ann Rev Virol 3:237\u2013261","journal-title":"Ann Rev Virol"},{"issue":"7807","key":"10016_CR77","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","volume":"581","author":"J Shang","year":"2020","unstructured":"Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, Geng Q, Auerbach A, Li F (2020) Structural basis of receptor recognition by SARS-CoV-2. Nature. 581(7807):221\u2013224","journal-title":"Nature."},{"issue":"5742","key":"10016_CR78","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1126\/science.1116480","volume":"309","author":"F Li","year":"2005","unstructured":"Li F, Li W, Farzan M, Harrison SC (2005) Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 309(5742):1864\u20131868","journal-title":"Science."},{"issue":"6965","key":"10016_CR79","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 426(6965):450\u2013454","journal-title":"Nature."},{"key":"10016_CR80","doi-asserted-by":"publisher","unstructured":"Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA, Fukamizu A, Hui CC, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM (2005) Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 436(7047):112\u2013116. https:\/\/doi.org\/10.1038\/nature03712","DOI":"10.1038\/nature03712"},{"issue":"5","key":"10016_CR81","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","volume":"43","author":"Y Ishiyama","year":"2004","unstructured":"Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM (2004) Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension. 43(5):970\u2013976","journal-title":"Hypertension."},{"issue":"9","key":"10016_CR82","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jacc.2008.02.088","volume":"52","author":"S Epelman","year":"2008","unstructured":"Epelman S, Tang WW, Chen SY, Van Lente F, Francis GS, Sen S (2008) Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system. J Am Coll Cardiol 52(9):750\u2013754","journal-title":"J Am Coll Cardiol"},{"key":"10016_CR83","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1093\/cvr\/cvaa097","volume":"116","author":"R Kreutz","year":"2020","unstructured":"Kreutz R, Algharably EAE-H, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, Persu A, Prejbisz A, Riemer TG, Wang JG, Burnier M (2020) Hypertension, the renin\u2013angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19 European Society of Hypertension COVID-19 Task Force Review of Evidence. Cardiovasc Res 116:1688\u20131699","journal-title":"Cardiovasc Res"},{"key":"10016_CR84","doi-asserted-by":"publisher","unstructured":"Fehr AR, Perlman S (2015) Coronaviruses: an overview of their replication and pathogenesis. In: Maier H., Bickerton E., Britton P. (eds) Coronaviruses. Methods in Molecular Biology, vol 1282. Humana Press, New York, NY. https:\/\/doi.org\/10.1007\/978-1-4939-2438-7_1","DOI":"10.1007\/978-1-4939-2438-7_1"},{"issue":"8","key":"10016_CR85","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","volume":"118","author":"VB Patel","year":"2016","unstructured":"Patel VB, Zhong J-C, Grant MB, Oudit GY (2016) Role of the ACE2\/angiotensin 1\u20137 axis of the renin\u2013angiotensin system in heart failure. Circ Res 118(8):1313\u20131326","journal-title":"Circ Res"},{"issue":"1","key":"10016_CR86","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","volume":"9","author":"J Meng","year":"2020","unstructured":"Meng J, Xiao G, Zhang J, He X, Ou M, Bi J, Yang R, di W, Wang Z, Li Z, Gao H, Liu L, Zhang G (2020) Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect 9(1):757\u2013760","journal-title":"Emerg Microbes Infect"},{"issue":"6","key":"10016_CR87","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","volume":"75","author":"AJ Danser","year":"2020","unstructured":"Danser AJ, Epstein M, Batlle D (2020) Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers. Hypertension. 75(6):1382\u20131385","journal-title":"Hypertension."},{"key":"10016_CR88","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.lfs.2016.04.013","volume":"153","author":"F Bai","year":"2016","unstructured":"Bai F, Pang X-F, Zhang L-H, Wang N-P, McKallip RJ, Garner RE et al (2016) Angiotensin II AT1 receptor alters ACE2 activity, eNOS expression and CD44-hyaluronan interaction in rats with hypertension and myocardial fibrosis. Life Sci 153:141\u2013152","journal-title":"Life Sci"},{"issue":"22","key":"10016_CR89","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1161\/01.CIR.0000131860.80444.AB","volume":"109","author":"I Mazak","year":"2004","unstructured":"Mazak I, Fiebeler A, Muller DN, Park J-K, Shagdarsuren E, Lindschau C, Dechend R, Viedt C, Pilz B, Haller H, Luft FC (2004) Aldosterone potentiates angiotensin II\u2013induced signaling in vascular smooth muscle cells. Circulation. 109(22):2792\u20132800","journal-title":"Circulation."},{"issue":"5","key":"10016_CR90","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.cardfail.2020.04.013","volume":"26","author":"B Bozkurt","year":"2020","unstructured":"Bozkurt B, Kovacs R, Harrington B (2020) Joint HFSA\/ACC\/AHA statement addresses concerns re: using RAAS antagonists in COVID-19. J Card Fail 26(5):370","journal-title":"J Card Fail"},{"key":"10016_CR91","doi-asserted-by":"publisher","unstructured":"Kuster GM, Pfister O, Burkard T, Zhou Q, Twerenbold R, Haaf P et al (2020) SARS-CoV2: should inhibitors of the renin\u2013angiotensin system be withdrawn in patients with COVID-19? Eur Heart J 41:1801\u20133. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa235.","DOI":"10.1093\/eurheartj\/ehaa235"},{"issue":"6","key":"10016_CR92","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10741-010-9165-7","volume":"15","author":"V Lionetti","year":"2010","unstructured":"Lionetti V, Bianchi G, Recchia FA, Ventura C (2010) Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure. Heart Fail Rev 15(6):531\u2013542","journal-title":"Heart Fail Rev"},{"key":"10016_CR93","doi-asserted-by":"publisher","unstructured":"Lionetti V, Barile L (2019) Perioperative cardioprotection: back to bedside. Minerva Anestesiol 86:445\u201354. https:\/\/doi.org\/10.23736\/S0375-9393.19.13848-5","DOI":"10.23736\/S0375-9393.19.13848-5"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-10016-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-020-10016-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-10016-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T11:52:13Z","timestamp":1650541933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-020-10016-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10016"],"URL":"https:\/\/doi.org\/10.1007\/s10741-020-10016-2","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"type":"print","value":"1382-4147"},{"type":"electronic","value":"1573-7322"}],"subject":[],"published":{"date-parts":[[2020,8,25]]},"assertion":[{"value":"25 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}